BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was PLN 13.45 million compared to PLN 6.55 million a year ago. Net income was PLN 1.54 million compared to net loss of PLN 0.577 million a year ago.
For the nine months, revenue was PLN 36.08 million compared to PLN 26.56 million a year ago. Net income was PLN 3.51 million compared to PLN 1.19 million a year ago. Basic earnings per share from continuing operations was PLN 0.05 compared to PLN 0.02 a year ago. Diluted earnings per share from continuing operations was PLN 0.05 compared to PLN 0.02 a year ago.